HEADER PROTEIN TRANSPORT 16-JUL-04 1WMS TITLE HIGH RESOLUTION CRYSTAL STRUCTURE OF HUMAN RAB9 GTPASE: A NOVEL TITLE 2 ANTIVIRAL DRUG TARGET COMPND MOL_ID: 1; COMPND 2 MOLECULE: RAS-RELATED PROTEIN RAB-9A; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: C-TERMINAL TRUNCATED; COMPND 5 SYNONYM: RAB-9, RAB9; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RAB9; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28-RAB9(1-177) KEYWDS GTPASE, PROTEIN TRANSPORT EXPDTA X-RAY DIFFRACTION AUTHOR L.CHEN,E.DIGIAMMARINO,X.E.ZHOU,Y.WANG,D.TOH,T.W.HODGE,E.J.MEEHAN REVDAT 3 25-OCT-23 1WMS 1 REMARK REVDAT 2 24-FEB-09 1WMS 1 VERSN REVDAT 1 14-SEP-04 1WMS 0 JRNL AUTH L.CHEN,E.DIGIAMMARINO,X.E.ZHOU,Y.WANG,D.TOH,T.W.HODGE, JRNL AUTH 2 E.J.MEEHAN JRNL TITL HIGH RESOLUTION CRYSTAL STRUCTURE OF HUMAN RAB9 GTPASE: A JRNL TITL 2 NOVEL ANTIVIRAL DRUG TARGET JRNL REF J.BIOL.CHEM. V. 279 40204 2004 JRNL REFN ISSN 0021-9258 JRNL PMID 15263003 JRNL DOI 10.1074/JBC.M407114200 REMARK 2 REMARK 2 RESOLUTION. 1.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 84.7 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.141 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.139 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.196 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 3697 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 73767 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.126 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.124 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.181 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 3093 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 61341 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2662 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 508 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 3229.0 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 2552.0 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 0 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 29064 REMARK 3 NUMBER OF RESTRAINTS : 34491 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 ANGLE DISTANCES (A) : 0.032 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.027 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.064 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.072 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.050 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.004 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.056 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.086 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL.91(1973)201-228 REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE STRUCTURE WAS REFINED ALSO WITH CNS REMARK 3 1.0 REMARK 4 REMARK 4 1WMS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 20-JUL-04. REMARK 100 THE DEPOSITION ID IS D_1000023754. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-MAR-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 73993 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.250 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 84.7 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : 0.06300 REMARK 200 FOR THE DATA SET : 25.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.29 REMARK 200 COMPLETENESS FOR SHELL (%) : 39.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.39200 REMARK 200 R SYM FOR SHELL (I) : 0.39200 REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1OIV REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG4000, SODIUM ACETATE, PH 5.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLN A 35 REMARK 465 LEU A 36 REMARK 465 PHE A 37 REMARK 465 HIS A 38 REMARK 465 GLU A 176 REMARK 465 ASP A 177 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 GLY B 3 REMARK 465 LYS B 4 REMARK 465 GLN B 35 REMARK 465 LEU B 36 REMARK 465 PHE B 37 REMARK 465 HIS B 38 REMARK 465 VAL B 111 REMARK 465 LYS B 112 REMARK 465 GLU B 113 REMARK 465 PRO B 114 REMARK 465 GLU B 176 REMARK 465 ASP B 177 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 SER A 5 C - N - CA ANGL. DEV. = 15.8 DEGREES REMARK 500 MET A 24 CA - CB - CG ANGL. DEV. = 16.2 DEGREES REMARK 500 ARG A 26 CG - CD - NE ANGL. DEV. = 14.5 DEGREES REMARK 500 ARG A 26 CD - NE - CZ ANGL. DEV. = 19.3 DEGREES REMARK 500 ARG A 26 NE - CZ - NH2 ANGL. DEV. = 5.5 DEGREES REMARK 500 TRP A 61 CG - CD1 - NE1 ANGL. DEV. = -7.2 DEGREES REMARK 500 TRP A 61 CD1 - NE1 - CE2 ANGL. DEV. = 11.9 DEGREES REMARK 500 TRP A 61 NE1 - CE2 - CD2 ANGL. DEV. = -7.7 DEGREES REMARK 500 ASP A 62 CB - CG - OD1 ANGL. DEV. = -7.1 DEGREES REMARK 500 ARG A 68 NE - CZ - NH1 ANGL. DEV. = -3.4 DEGREES REMARK 500 ARG A 73 NE - CZ - NH1 ANGL. DEV. = 4.3 DEGREES REMARK 500 TYR A 77 CB - CG - CD1 ANGL. DEV. = 5.3 DEGREES REMARK 500 ARG A 131 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG A 171 NE - CZ - NH2 ANGL. DEV. = -3.2 DEGREES REMARK 500 SER B 6 C - N - CA ANGL. DEV. = 28.7 DEGREES REMARK 500 MET B 24 CA - CB - CG ANGL. DEV. = 21.4 DEGREES REMARK 500 ARG B 26 NE - CZ - NH2 ANGL. DEV. = -5.1 DEGREES REMARK 500 TRP B 61 CG - CD1 - NE1 ANGL. DEV. = -8.1 DEGREES REMARK 500 TRP B 61 CD1 - NE1 - CE2 ANGL. DEV. = 12.1 DEGREES REMARK 500 TRP B 61 NE1 - CE2 - CD2 ANGL. DEV. = -7.7 DEGREES REMARK 500 ASP B 110 C - N - CA ANGL. DEV. = -16.8 DEGREES REMARK 500 ARG B 131 NE - CZ - NH1 ANGL. DEV. = 5.0 DEGREES REMARK 500 TYR B 148 CB - CG - CD2 ANGL. DEV. = -3.8 DEGREES REMARK 500 ARG B 171 CG - CD - NE ANGL. DEV. = 18.2 DEGREES REMARK 500 ARG B 171 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 ARG B 171 NE - CZ - NH2 ANGL. DEV. = -3.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 125 35.83 73.68 REMARK 500 ALA A 158 -1.94 78.31 REMARK 500 SER B 6 124.23 -37.07 REMARK 500 LYS B 125 37.66 76.58 REMARK 500 ALA B 158 0.70 83.30 REMARK 500 ASN B 160 12.72 57.70 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ALA A 174 THR A 175 134.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GDP A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GDP B 1002 DBREF 1WMS A 1 177 UNP P51151 RAB9A_HUMAN 1 177 DBREF 1WMS B 1 177 UNP P51151 RAB9A_HUMAN 1 177 SEQRES 1 A 177 MET ALA GLY LYS SER SER LEU PHE LYS VAL ILE LEU LEU SEQRES 2 A 177 GLY ASP GLY GLY VAL GLY LYS SER SER LEU MET ASN ARG SEQRES 3 A 177 TYR VAL THR ASN LYS PHE ASP THR GLN LEU PHE HIS THR SEQRES 4 A 177 ILE GLY VAL GLU PHE LEU ASN LYS ASP LEU GLU VAL ASP SEQRES 5 A 177 GLY HIS PHE VAL THR MET GLN ILE TRP ASP THR ALA GLY SEQRES 6 A 177 GLN GLU ARG PHE ARG SER LEU ARG THR PRO PHE TYR ARG SEQRES 7 A 177 GLY SER ASP CYS CYS LEU LEU THR PHE SER VAL ASP ASP SEQRES 8 A 177 SER GLN SER PHE GLN ASN LEU SER ASN TRP LYS LYS GLU SEQRES 9 A 177 PHE ILE TYR TYR ALA ASP VAL LYS GLU PRO GLU SER PHE SEQRES 10 A 177 PRO PHE VAL ILE LEU GLY ASN LYS ILE ASP ILE SER GLU SEQRES 11 A 177 ARG GLN VAL SER THR GLU GLU ALA GLN ALA TRP CYS ARG SEQRES 12 A 177 ASP ASN GLY ASP TYR PRO TYR PHE GLU THR SER ALA LYS SEQRES 13 A 177 ASP ALA THR ASN VAL ALA ALA ALA PHE GLU GLU ALA VAL SEQRES 14 A 177 ARG ARG VAL LEU ALA THR GLU ASP SEQRES 1 B 177 MET ALA GLY LYS SER SER LEU PHE LYS VAL ILE LEU LEU SEQRES 2 B 177 GLY ASP GLY GLY VAL GLY LYS SER SER LEU MET ASN ARG SEQRES 3 B 177 TYR VAL THR ASN LYS PHE ASP THR GLN LEU PHE HIS THR SEQRES 4 B 177 ILE GLY VAL GLU PHE LEU ASN LYS ASP LEU GLU VAL ASP SEQRES 5 B 177 GLY HIS PHE VAL THR MET GLN ILE TRP ASP THR ALA GLY SEQRES 6 B 177 GLN GLU ARG PHE ARG SER LEU ARG THR PRO PHE TYR ARG SEQRES 7 B 177 GLY SER ASP CYS CYS LEU LEU THR PHE SER VAL ASP ASP SEQRES 8 B 177 SER GLN SER PHE GLN ASN LEU SER ASN TRP LYS LYS GLU SEQRES 9 B 177 PHE ILE TYR TYR ALA ASP VAL LYS GLU PRO GLU SER PHE SEQRES 10 B 177 PRO PHE VAL ILE LEU GLY ASN LYS ILE ASP ILE SER GLU SEQRES 11 B 177 ARG GLN VAL SER THR GLU GLU ALA GLN ALA TRP CYS ARG SEQRES 12 B 177 ASP ASN GLY ASP TYR PRO TYR PHE GLU THR SER ALA LYS SEQRES 13 B 177 ASP ALA THR ASN VAL ALA ALA ALA PHE GLU GLU ALA VAL SEQRES 14 B 177 ARG ARG VAL LEU ALA THR GLU ASP HET GDP A1001 28 HET GDP B1002 28 HETNAM GDP GUANOSINE-5'-DIPHOSPHATE FORMUL 3 GDP 2(C10 H15 N5 O11 P2) FORMUL 5 HOH *508(H2 O) HELIX 1 1 GLY A 19 ASN A 30 1 12 HELIX 2 2 GLN A 66 ARG A 68 5 3 HELIX 3 3 PHE A 69 THR A 74 1 6 HELIX 4 4 PRO A 75 ARG A 78 5 4 HELIX 5 5 ASP A 91 ASN A 97 1 7 HELIX 6 6 ASN A 97 ASP A 110 1 14 HELIX 7 7 SER A 134 ASN A 145 1 12 HELIX 8 8 ASN A 160 ALA A 174 1 15 HELIX 9 9 GLY B 19 ASN B 30 1 12 HELIX 10 10 GLN B 66 ARG B 68 5 3 HELIX 11 11 PHE B 69 THR B 74 1 6 HELIX 12 12 PRO B 75 ARG B 78 5 4 HELIX 13 13 ASP B 91 ASN B 97 1 7 HELIX 14 14 ASN B 97 ALA B 109 1 13 HELIX 15 15 SER B 134 ASN B 145 1 12 HELIX 16 16 ASN B 160 THR B 175 1 16 SHEET 1 A12 TYR A 150 GLU A 152 0 SHEET 2 A12 PHE A 119 ASN A 124 1 N GLY A 123 O PHE A 151 SHEET 3 A12 CYS A 82 SER A 88 1 N PHE A 87 O ASN A 124 SHEET 4 A12 SER A 5 LEU A 13 1 N ILE A 11 O LEU A 84 SHEET 5 A12 HIS A 54 ASP A 62 1 O THR A 57 N SER A 6 SHEET 6 A12 VAL A 42 VAL A 51 -1 N LYS A 47 O MET A 58 SHEET 7 A12 VAL B 42 VAL B 51 -1 O VAL B 42 N PHE A 44 SHEET 8 A12 HIS B 54 ASP B 62 -1 O MET B 58 N LYS B 47 SHEET 9 A12 LEU B 7 LEU B 13 1 N PHE B 8 O GLN B 59 SHEET 10 A12 CYS B 82 SER B 88 1 O LEU B 84 N ILE B 11 SHEET 11 A12 PHE B 119 ASN B 124 1 O ASN B 124 N PHE B 87 SHEET 12 A12 TYR B 150 GLU B 152 1 O PHE B 151 N GLY B 123 CISPEP 1 SER B 5 SER B 6 0 4.76 SITE 1 AC1 26 GLY A 17 VAL A 18 GLY A 19 LYS A 20 SITE 2 AC1 26 SER A 21 SER A 22 PHE A 32 THR A 34 SITE 3 AC1 26 ASN A 124 LYS A 125 ASP A 127 SER A 154 SITE 4 AC1 26 ALA A 155 LYS A 156 HOH A1004 HOH A1017 SITE 5 AC1 26 HOH A1029 HOH A1031 HOH A1042 HOH A1081 SITE 6 AC1 26 HOH A1094 HOH A1146 HOH A1239 ARG B 78 SITE 7 AC1 26 ASP B 110 HOH B1106 SITE 1 AC2 22 GLY B 17 VAL B 18 GLY B 19 LYS B 20 SITE 2 AC2 22 SER B 21 SER B 22 PHE B 32 THR B 34 SITE 3 AC2 22 ASN B 124 LYS B 125 ASP B 127 ILE B 128 SITE 4 AC2 22 SER B 154 ALA B 155 LYS B 156 HOH B1025 SITE 5 AC2 22 HOH B1048 HOH B1084 HOH B1137 HOH B1138 SITE 6 AC2 22 HOH B1161 HOH B1226 CRYST1 38.400 45.620 51.220 99.75 107.17 101.84 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026042 0.005459 0.009686 0.00000 SCALE2 0.000000 0.022397 0.005681 0.00000 SCALE3 0.000000 0.000000 0.021081 0.00000